CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer. - Ahmad S; Butle A; Karn A; Sunder R; Mishra R; Bawaskar B; Parab P; Raje V; Chaubal R; Shet T; Kundu G; Gupta S; et al. (British journal of cancer, 2026)